Episode Details
Back to Episodes
Wegovy Added to Pharmac's Investment List
Description
Pharmac has added Wegovy, a weight-loss drug, to its investment list, potentially making it eligible for funding in the future. The drug is intended for individuals with a BMI of 35 or higher and at least two related health issues. The advisory group initially prioritized it for those with a BMI over 30, but the rules were tightened to match other countries standards. The high prevalence of obesity in New Zealand could lead to significant demand and budget strain. The drugs eligibility depends on meeting specific BMI and health criteria, and treatment may stop if weight loss goals are not met. The final decision on funding will be determined by budget discussions.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/cf2b8688c7a2698f